Back
Biomarin Pharmaceutical Stock Price Chart
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Buy
62
BMRN
Biomarin Pharmaceutical
Last Price:
$59.77
Seasonality Move:
3.2%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.36 | Sell |
| 20-day SMA: | 61.08 | Sell |
| 50-day SMA: | 65.15 | Sell |
| 200-day SMA: | 70.22 | Sell |
| 8-day EMA: | 60.45 | Sell |
| 20-day EMA: | 61.33 | Sell |
| 50-day EMA: | 63.36 | Sell |
| 200-day EMA: | 69.57 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.08 | Sell |
| Relative Strength Index (14 RSI): | 42.9 | Sell |
| Chaikin Money Flow: | -981572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.22 - 62.56) | Sell |
| Bollinger Bands (100): | (60.95 - 69.47) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 59.78 while BMRN 8-day simple moving average is 60.36, which is a Sell signal.
-
The stock price of BMRN is 59.78 while Biomarin Pharmaceutical 20-day SMA is 61.08, which makes it a Sell.
-
Biomarin Pharmaceutical 50-day simple moving average is 65.15 while BMRN share price is 59.78, making it a Sell technically.
-
BMRN stock price is 59.78 and Biomarin Pharmaceutical 200-day simple moving average is 70.22, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
62
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a BuyThe current Biomarin Pharmaceutical [BMRN] share price is $59.78. The Score for BMRN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
11.5B
Price in USD:
59.78
Share Volume:
1.7M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
94.85
52-Week Low:
52.93
Buy
62
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?The Biomarin Pharmaceutical stock price is 59.78 USD today.
-
Will BMRN stock go up or go down?Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Biomarin Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 59.78 while BMRN 8-day exponential moving average is 60.45, which is a Sell signal.
-
The stock price of BMRN is 59.78 while Biomarin Pharmaceutical 20-day EMA is 61.33, which makes it a Sell.
-
Biomarin Pharmaceutical 50-day exponential moving average is 63.36 while BMRN share price is 59.78, making it a Sell technically.
-
BMRN stock price is 59.78 and Biomarin Pharmaceutical 200-day simple moving average is 69.57, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.18 per share, an increase this year of $1.01 per share, and an increase next year of $1.01 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is -1.08, suggesting Biomarin Pharmaceutical is a Sell
-
Biomarin Pharmaceutical Relative Strength Index (RSI) is 42.9, which suggest Biomarin Pharmaceutical is oversold
-
The Bollinger Bands (25) for Biomarin Pharmaceutical is (58.22 - 62.56), which suggest Biomarin Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Biomarin Pharmaceutical is (60.95 - 69.47), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.